RVTY.NYSERevvity, INC

Form 4: Revvity Officer Anita Gonzales Reports Stock and Option Transactions

Sentiment:

SEC Form 4 Filing


Anita Gonzales, a Vice President and Controller at Revvity, Inc., reported the acquisition of restricted stock units and stock options, as well as the disposal of common stock.

Summary

  • On March 1, 2024, Anita Gonzales, a Vice President and Controller at Revvity, Inc., reported transactions involving the company's securities.
  • Gonzales acquired 715 shares of common stock and disposed of 4,306 shares.
  • She also acquired options to purchase 1,978 shares of common stock at an exercise price of $107.48.
  • The restricted stock units vest in three equal annual installments starting on the first anniversary of the grant date.
  • The stock options also vest in three equal annual installments beginning on the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing and does not inherently convey positive or negative sentiment. The transactions themselves could be interpreted in different ways, but without additional context, a neutral sentiment is appropriate.

Positives

  • The acquisition of restricted stock units and stock options could indicate confidence in the company's future performance.

Negatives

  • The disposal of 4,306 shares of common stock could be interpreted negatively, although the reason for the disposal is not specified.

Risks

  • The vesting schedule of the restricted stock units and options could create pressure for short-term performance to meet vesting requirements.
  • Fluctuations in the stock price could impact the value of the options and restricted stock units.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies and their insiders. They provide transparency into the trading activities of company officers and directors.

Comparison to Industry Standards

  • Stock option grants and restricted stock units are common forms of executive compensation in the technology and life sciences industries, often vesting over a three-to-four year period.
  • The vesting schedule of three equal annual installments is a fairly standard practice.
  • Comparing the size of the grant to similar companies like Danaher (DHR) or Agilent Technologies (A) would provide further context on the magnitude of the compensation.

Stakeholder Impact

  • The transactions reported in the Form 4 filing provide transparency to shareholders regarding the trading activities of company insiders.
  • The vesting schedule of the restricted stock units and options could incentivize management to focus on long-term value creation.

Key Dates

DateDescription
03/01/2024Date of the reported transactions (acquisition and disposal of common stock and acquisition of stock options).
03/01/2031Expiration date of the NQ Stock Option.
03/21/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.